Clinic for Obstetrics, Gynecology and Andrology of Large and Small Animals, Justus-Liebig-University Giessen, 35392 Giessen, Germany.
Reproduction. 2010 Mar;139(3):655-64. doi: 10.1530/REP-09-0140. Epub 2009 Nov 24.
Expression of cyclooxygenase 2 (COX2, now known as PTGS2), prostaglandin E2 synthase (PTGES, PGES), and prostaglandin F2alpha synthase (PGFS), of the respective receptors PTGFR (FP), PTGER2 (EP2), and PTGER4 (EP4) and of the progesterone receptor (PGR, PR) was assessed by real-time PCR, immunohistochemistry (IHC), or in situ hybridization (ISH) in utero/placental tissue samples collected from three to five bitches on days 8-12 (pre-implantation), 18-25 (post-implantation), and 35-40 (mid-gestation) of pregnancy and during the prepartal luteolysis. Additionally, ten mid-pregnant bitches were treated with the antiprogestin aglepristone (10 mg/kg bw (2x/24 h)); ovariohysterectomy was 24 and 72 h after the second treatment. Plasma progesterone and 15-ketodihydro-PGF2alpha (PGFM) concentrations were determined by RIA. Expression of the PGR was highest before implantation and primarily located to the endometrium; expression in the placenta was restricted to the decidual cells. PTGS2 was constantly low expressed until mid-gestation; a strong upregulation occurred at prepartal luteolysis concomitant with an increase in PGFM. PGFS was upregulated after implantation and significantly elevated through early and mid-gestation. PTGES showed a gradual increase and a strong prepartal upregulation. PTGFR, PTGER2, and PTGER4 were downregulated after implantation; a gradual upregulation of PTGFR and PTGER2 occurred towards parturition. ISH and IHC co-localized PGFS, PTGFR, PTGES, and PTGS2 in the trophoblast and endometrium. The changes following application of aglepristone were in the same direction as those observed from mid-gestation to prepartal luteolysis. These data suggest that the prepartal increase of PGF2alpha results from a strong upregulation of PTGS2 in the fetal trophoblast with the withdrawal of progesterone having a signalling function and the decidual cells playing a key role in the underlying cell-to-cell crosstalk.
环氧化酶 2 (COX2,现在称为 PTGS2)、前列腺素 E2 合酶 (PTGES、PGES) 和前列腺素 F2alpha 合酶 (PGFS)、各自的受体 PTGFR (FP)、PTGER2 (EP2) 和 PTGER4 (EP4) 以及孕激素受体 (PGR,PR) 的表达通过实时 PCR、免疫组织化学 (IHC) 或原位杂交 (ISH) 在妊娠和分娩前黄体溶解期间从怀孕 8-12 天 (着床前)、18-25 天 (着床后) 和 35-40 天 (中期妊娠) 收集的三只到五只母犬的子宫/胎盘组织样本中进行评估。此外,十只妊娠中期的母犬用抗孕激素 aglepristone(10 mg/kg bw (2x/24 h))治疗;第二次治疗后 24 和 72 小时进行卵巢子宫切除术。通过 RIA 测定血浆孕酮和 15-酮二氢-PGF2alpha (PGFM) 浓度。PGR 的表达在着床前最高,主要位于子宫内膜;胎盘中的表达仅限于蜕膜细胞。PTGS2 在妊娠中期之前一直低表达;分娩前黄体溶解时强烈上调,同时 PGFM 增加。PGFS 在着床后上调,并在早期和中期妊娠期间显着升高。PTGES 逐渐增加,并在分娩前强烈上调。PTGFR、PTGER2 和 PTGER4 在着床后下调;分娩前逐渐上调 PTGFR 和 PTGER2。ISH 和 IHC 将 PGFS、PTGFR、PTGES 和 PTGS2 共定位在滋养层和子宫内膜中。应用 aglepristone 后的变化与从中期妊娠到分娩前黄体溶解的变化方向相同。这些数据表明,PGF2alpha 的分娩前增加是由于胎儿滋养层中 PTGS2 的强烈上调,而孕酮的撤退具有信号功能,蜕膜细胞在细胞间信号转导中发挥关键作用。